Veliparib With or Without Radiation Therapy, Carboplatin, and Paclitaxel in Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery

NCT01386385 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

53

Enrollment

NIH

Sponsor class

Conditions

Lung Adenocarcinoma
Lung Adenocarcinoma, Mixed Subtype
Lung Large Cell Carcinoma
Lung Squamous Cell Carcinoma
Minimally Invasive Lung Adenocarcinoma
Stage III Lung Non-Small Cell Cancer AJCC v7
Stage IIIA Lung Non-Small Cell Cancer AJCC v7
Stage IIIB Lung Non-Small Cell Cancer AJCC v7

Interventions

RADIATION: 3-Dimensional Conformal Radiation Therapy
DRUG: Carboplatin
OTHER: Laboratory Biomarker Analysis
DRUG: Paclitaxel
OTHER: Placebo Administration
DRUG: Veliparib

Sponsor

National Cancer Institute (NCI)